BioCentury | Oct 23, 2020
Product Development

What’s next for targeted protein degradation

...also increasingly being used as tools for target discovery...
BioCentury | Sep 25, 2020
Product Development

Flagship’s Valo takes stab at cloud-based R&D with $96.5M and longitudinal human data

...test with Valo Health LLC, whose cloud computing platform is geared to guide everything from target discovery...
...“the skeleton of a closed loop” strategy, Berry said.According to Berry, Valo’s Opal platform guides target discovery...
BioCentury | Jun 17, 2020
Deals

With Ideaya deal, GSK bulks up synthetic lethality side of oncology business

...space. Last June, GSK CSO and President of R&D Hal Barron told BioCentury synthetic lethality target discovery...
BioCentury | May 27, 2020
Deals

Sanofi's sale of Regeneron stake for $11B could set stage for both companies' growth through M&A

...via its genetic research, with deal structures that can leverage its expertise in antibody and target discovery...
BioCentury | May 22, 2020
Finance

Nautilus raises $76M series B to deliver next-generation proteomics to the lab

...its own internal pipeline, Mallick said its technology can be applied to therapeutics -- for target discovery...
BioCentury | Mar 7, 2020
Product Development

If NoNO’s stroke trial strategy pays off, it could bring the first new therapy in a generation

...to try to develop neuroprotectants.” Michael Tymianski, NoNO The company, which has taken PSD95 from target discovery...
BioCentury | Feb 29, 2020
Management Tracks

Brandicourt joins Alnylam's board: plus Bayer, Jazz, Halozyme, Arena, Aurinia, Adverum, Neoleukin, Centogene, Epirium, Insilico, Nouscom, Eloxx, Nordic, Summit,

...Capital. Insilico Medicine Inc. hired George Okafo as entrepreneur-in-residence. He will use the company’s AI-driven target discovery...
BioCentury | Feb 21, 2020
Emerging Company Profile

Montis: Exploring an untouched macrophage subset in immuno-oncology

...immunosuppresive cells such as regulatory T cells. Montis paired single cell RNA sequencing with a target discovery...
BioCentury | Jan 16, 2020
Company News

Galapagos to build fibrosis pipeline via extended Fibrocor partnership

...Galapagos' next most advanced IPF therapy, GPR84 inhibitor GLPG1205, is in Phase II. For fibrosis target discovery...
BioCentury | Jan 11, 2020
Company News

Camp4’s platform to discover CNS targets in Biogen partnership

...liver indications, Camp4 has entered a collaboration with Biogen to apply its platform to CNS target discovery...
Items per page:
1 - 10 of 348
BioCentury | Oct 23, 2020
Product Development

What’s next for targeted protein degradation

...also increasingly being used as tools for target discovery...
BioCentury | Sep 25, 2020
Product Development

Flagship’s Valo takes stab at cloud-based R&D with $96.5M and longitudinal human data

...test with Valo Health LLC, whose cloud computing platform is geared to guide everything from target discovery...
...“the skeleton of a closed loop” strategy, Berry said.According to Berry, Valo’s Opal platform guides target discovery...
BioCentury | Jun 17, 2020
Deals

With Ideaya deal, GSK bulks up synthetic lethality side of oncology business

...space. Last June, GSK CSO and President of R&D Hal Barron told BioCentury synthetic lethality target discovery...
BioCentury | May 27, 2020
Deals

Sanofi's sale of Regeneron stake for $11B could set stage for both companies' growth through M&A

...via its genetic research, with deal structures that can leverage its expertise in antibody and target discovery...
BioCentury | May 22, 2020
Finance

Nautilus raises $76M series B to deliver next-generation proteomics to the lab

...its own internal pipeline, Mallick said its technology can be applied to therapeutics -- for target discovery...
BioCentury | Mar 7, 2020
Product Development

If NoNO’s stroke trial strategy pays off, it could bring the first new therapy in a generation

...to try to develop neuroprotectants.” Michael Tymianski, NoNO The company, which has taken PSD95 from target discovery...
BioCentury | Feb 29, 2020
Management Tracks

Brandicourt joins Alnylam's board: plus Bayer, Jazz, Halozyme, Arena, Aurinia, Adverum, Neoleukin, Centogene, Epirium, Insilico, Nouscom, Eloxx, Nordic, Summit,

...Capital. Insilico Medicine Inc. hired George Okafo as entrepreneur-in-residence. He will use the company’s AI-driven target discovery...
BioCentury | Feb 21, 2020
Emerging Company Profile

Montis: Exploring an untouched macrophage subset in immuno-oncology

...immunosuppresive cells such as regulatory T cells. Montis paired single cell RNA sequencing with a target discovery...
BioCentury | Jan 16, 2020
Company News

Galapagos to build fibrosis pipeline via extended Fibrocor partnership

...Galapagos' next most advanced IPF therapy, GPR84 inhibitor GLPG1205, is in Phase II. For fibrosis target discovery...
BioCentury | Jan 11, 2020
Company News

Camp4’s platform to discover CNS targets in Biogen partnership

...liver indications, Camp4 has entered a collaboration with Biogen to apply its platform to CNS target discovery...
Items per page:
1 - 10 of 348